Single-molecule Plasmonic Detection Nucleic Acids Patent Application Us

Single-Molecule Plasmonic Detection Nucleic Acids Patent Application US

Introduction

Single-molecule plasmonic detection of nucleic acids is reshaping the landscape of molecular diagnostics. By harnessing localized surface plasmon resonance (LSPR) at the nanoscale, the technology enables real‑time, label‑free detection of DNA or RNA targets directly at the single‑molecule level. In practice, this patent application US focuses on a plasmonic sensor platform capable of identifying individual nucleic acid strands with unprecedented sensitivity. The following article breaks down the core concepts, outlines the procedural steps of the patent filing, explains the underlying science, and addresses common questions that researchers and industry professionals may have Simple as that..

Overview of Plasmonic Detection

What Is Plasmonics?

Plasmonics refers to the interaction between light and free electrons in metallic nanostructures. When incident light hits a metal nanoparticle, it excites collective oscillations of conduction electrons—known as surface plasmons. These oscillations concentrate electromagnetic fields into volumes far smaller than the wavelength of light, creating hot spots that amplify optical signals.

How Plasmonic Sensors Work

1. Nanoparticle Functionalization – Gold or silver nanoparticles are coated with capture probes (e.g., oligonucleotide primers) that specifically bind to the target nucleic acid.
2. Binding Event – When a target strand hybridizes to the probe, the particle’s optical properties shift, altering the plasmon resonance wavelength or intensity.
3. Single‑Molecule Sensitivity – Because each binding event produces a measurable change in the localized field, the sensor can detect even a solitary nucleic acid molecule, a feat unattainable with conventional fluorescence or ELISA assays.

Steps in the Patent Application US

The single-molecule plasmonic detection nucleic acids patent application US follows a structured workflow to secure reliable intellectual property protection. Below is a concise, numbered outline of the key procedural stages Worth keeping that in mind..

1. Inventor Identification

   • List all individuals who contributed to the conception of the detection method, apparatus, or experimental data.
   • Verify residency requirements for US patent filers (U.S. citizenship or legal residence).

2. Prior Art Search

   • Conduct a comprehensive search of existing patents, scientific literature, and conference proceedings related to plasmonic nucleic acid detection.
   • Use databases such as USPTO, Google Patents, and PubMed to identify overlapping claims.

3. Drafting the Specification

   • Background: Summarize the limitations of current nucleic acid detection techniques (e.g., sensitivity, labeling requirements).
   • Summary of the Invention: Clearly state the novel aspects—nanoparticle design, hybridization conditions, signal interpretation, and data analysis pipelines.
   • Detailed Description: Provide embodiments, experimental examples, and detailed schematics of the sensor chip, optical setup, and data acquisition software.

4. Claims Construction

   • Draft independent claims that define the broadest protective scope (e.g., a method for detecting a single nucleic acid molecule using a plasmonic nanoparticle).
   • Include dependent claims that specify optional features such as specific nanoparticle materials, surface chemistries, or signal‑processing algorithms.

5. Drawings

   • Submit high‑quality figures that illustrate:
     • The overall sensor architecture (H2 diagram).
     • A step‑by‑step flowchart of the detection process (H3 sub‑figure).
     • Representative spectroscopic data before and after target binding (H3 inset).

6. Filing with USPTO

   • Submit the electronic application via the Patent Electronic Application System (PEAS).
   • Pay the required filing, search, and examination fees.

7. Prosecution

   • Respond to any Office Actions by amending claims, providing arguments, or submitting additional data.
   • Maintain a clear record of all correspondence for future reference.

8. Allowance and Issuance

   • Once the examiner finds the claims acceptable, a Notice of Allowance is issued.
   • Pay the issue fee, and the patent is granted, conferring exclusive rights for up to 20 years from the filing date.

Scientific Explanation

Localized Surface Plasmon Resonance (LSPR)

The core physical principle behind the detection is LSPR. When light of a specific wavelength irradiates a metallic nanoparticle, the conduction electrons resonate at their natural frequency, producing a sharp peak in the extinction spectrum. The resonance frequency is highly sensitive to the environmental refractive index surrounding the particle.

• Binding of a nucleic acid strand changes the local refractive index near the nanoparticle surface, causing a measurable red‑shift (≈ 5–15 nm) or intensity change in the LSPR peak.
• Because the electromagnetic field is confined to a few nanometers from the particle surface, even a single molecule can induce a detectable shift, especially when the particle size is below 20 nm.

Nanoparticle Design Considerations

• Material: Gold (Au) is preferred for its chemical stability and strong plasmonic response in the visible–near‑infrared range.
• Size: Sub‑20 nm diameters maximize field confinement while minimizing non‑radiative damping.
• Surface Coating: A thin layer of silica or polymer can be applied to prevent aggregation and to provide a stable platform for oligonucleotide attachment via thiol‑linkage chemistry.

Signal Amplification Strategies

To enhance the detection of single molecules, the patent application incorporates several innovative strategies:

• Nano‑Antenna Arrays: Positioning multiple nanoparticles in a periodic array creates hot‑spot coupling, amplifying the plasmonic signal per molecule.
• Reporter Molecules: Incorporating a secondary fluorophore that interacts with the plasmonic field (e.g., via Förster resonance energy transfer) boosts the readout without compromising label‑free capability.
• Temperature Control: Maintaining a stable temperature (± 0.1 °C) reduces thermal drift in the LSPR peak, improving measurement reproducibility.

Advantages and Applications

Unmatched Sensitivity

Traditional nucleic acid detection methods often require amplification (PCR) or labeling (fluorescent tags) to reach single‑molecule detection limits. The single-molecule plasmonic detection described in the US patent eliminates the need for both, delivering:

• Direct detection of native DNA/RNA strands.
• Rapid turnaround (minutes) compared with hours for conventional assays.

Label‑Free and Real‑Time

The absence of fluorescent or enzymatic labels reduces photobleaching and non‑specific binding, while enabling continuous monitoring of molecular interactions in real time Less friction, more output..

Versatile Platform

Potential applications span:

• Clinical diagnostics (early detection of pathogens, cancer biomarkers).
• Environmental monitoring (trace DNA detection in water samples).
• Synthetic biology (quantifying gene expression at the single‑molecule level).

Cost‑Effectiveness

Because the assay relies on simple optical measurements (e.Consider this: g. , a spectrophotometer or a low‑cost spectrometer), operational expenses remain low, making the technology attractive for point‑of‑care devices But it adds up..

Frequently Asked Questions (FAQ)

Q1: How does this method differ from CRISPR‑based detection?
A: CRISPR systems rely on nucleic acid cleavage and collateral cleavage activity, often coupled with a reporter dye. In contrast, the plasmonic approach detects hybridization directly, offering a label‑free, optical readout without enzymatic steps Turns out it matters..

Q2: Is the sensor reusable?
A: The patent discloses a regenerable functionalization strategy where the capture probes can be stripped and re‑equilibrated using mild buffer washes, allowing multiple cycles of detection Surprisingly effective..

Q3: What is the limit of detection (LOD) reported?
A: Experimental data in the application demonstrate an LOD of single‑molecule level, verified through Poisson statistics on fluorescence‑independent optical signals.

Q4: Are there any regulatory considerations for clinical use?
A: Since the technology is label‑free and uses biocompatible gold nanoparticles, it aligns well with FDA and EMA guidelines for in‑vitro diagnostic devices. Even so, the patent applicant must conduct clinical validation to satisfy regulatory pathways Simple, but easy to overlook..

Q5: Can the platform be integrated into portable devices?
A: Yes. The optical setup can be miniaturized using micro‑spectrometers and LED light sources, enabling integration into handheld or smartphone‑based diagnostic tools It's one of those things that adds up..

Conclusion

The single-molecule plasmonic detection nucleic acids patent application US exemplifies how nanophotonic engineering can push diagnostic sensitivity to the ultimate frontier—detecting individual nucleic acid strands without labels or amplification. By leveraging localized surface plasmon resonance, innovative nanoparticle design, and a streamlined patent filing process, the invention offers a powerful tool for researchers, clinicians, and industry stakeholders seeking rapid, accurate, and cost‑effective molecular diagnostics. As the technology matures, it is poised to influence a broad spectrum of applications, from early disease detection to environmental surveillance, reinforcing the key role of plasmonics in next‑generation biosensing.

Most guides skip this. Don't.

Key takeaways:

• Single‑molecule sensitivity is achieved through nanoscale field confinement.
• The patent workflow includes inventor identification, prior art search, detailed specification drafting, claim construction, and USPTO filing.
• Advantages include label‑free operation, real‑time monitoring, and versatile applicability across multiple sectors.

By understanding both the scientific underpinnings and the procedural nuances of the US patent application, stakeholders can better appreciate the transformative potential of this emerging detection platform It's one of those things that adds up..